Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

General dermatologic use of hydroxamic acid

E Solano

    Clinical Therapeutics
    |January 1, 1980
    PubMed
    Summary

    Topical bufexamac cream demonstrated significant anti-inflammatory efficacy in treating mild to moderate dermatoses, with 86% of patients showing good to very good responses. This study highlights bufexamac as a safe and effective treatment option for various skin conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quantum Phase Transitions for an Integrable Quantum Rabi-like Model with Two Interacting Qubits.

    Physical review letters·2023
    Same author

    Quantum Simulation of the Bosonic Creutz Ladder with a Parametric Cavity.

    Physical review letters·2021
    Same author

    Experimental semi-autonomous eigensolver using reinforcement learning.

    Scientific reports·2021
    Same author

    Speeding up quantum perceptron via shortcuts to adiabaticity.

    Scientific reports·2021
    Same author

    Degree of Quantumness in Quantum Synchronization.

    Scientific reports·2019
    Same author

    A giant exoplanet orbiting a very-low-mass star challenges planet formation models.

    Science (New York, N.Y.)·2019

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Dermatoses encompass a range of inflammatory skin conditions.
    • Bufexamac is a hydroxamic acid derivative with known anti-inflammatory properties.

    Purpose of the Study:

    • To evaluate the efficacy and safety of topical bufexamac cream in patients with mild to moderate dermatoses.
    • To assess treatment response across different diagnostic categories of dermatitis.

    Main Methods:

    • A clinical trial involving 50 patients with mild to moderate dermatoses.
    • Patients were treated with bufexamac cream for three weeks.
    • Signs and symptoms were evaluated weekly, with grading of response.

    Main Results:

    • 86% of patients (43 out of 50) achieved a good or very good response to bufexamac treatment.
    • Higher efficacy was observed in patients with seborrheic, contact, or solar dermatitis.
    • No adverse side effects were reported during the study period.

    Conclusions:

    • Topical bufexamac cream is an effective and safe treatment for mild to moderate dermatoses.
    • The compound shows particular promise for inflammatory conditions like seborrheic and contact dermatitis.
    • Bufexamac represents a valuable therapeutic option with a favorable safety profile.

    Related Experiment Videos